200 related articles for article (PubMed ID: 35850542)
1. Rethinking intercurrent events in defining estimands for tuberculosis trials.
Pham TM; Tweed CD; Carpenter JR; Kahan BC; Nunn AJ; Crook AM; Esmail H; Goodall R; Phillips PP; White IR
Clin Trials; 2022 Oct; 19(5):522-533. PubMed ID: 35850542
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
[TBL] [Abstract][Full Text] [Related]
4. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PPJ
Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
[TBL] [Abstract][Full Text] [Related]
5. Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PP
Res Sq; 2023 Nov; ():. PubMed ID: 37986887
[TBL] [Abstract][Full Text] [Related]
6. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
Qu Y; Shurzinske L; Sethuraman S
Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
[TBL] [Abstract][Full Text] [Related]
7. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction.
Keene ON
Pharm Stat; 2019 Jan; 18(1):78-84. PubMed ID: 30370691
[TBL] [Abstract][Full Text] [Related]
8. Estimand framework: Delineating what to be estimated with clinical questions of interest in clinical trials.
Jin M; Liu G
Contemp Clin Trials; 2020 Sep; 96():106093. PubMed ID: 32777382
[TBL] [Abstract][Full Text] [Related]
9. A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?
Mitroiu M; Oude Rengerink K; Teerenstra S; Pétavy F; Roes KCB
Trials; 2020 Jul; 21(1):671. PubMed ID: 32703247
[TBL] [Abstract][Full Text] [Related]
10. Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey.
Fletcher C; Hefting N; Wright M; Bell J; Anzures-Cabrera J; Wright D; Lynggaard H; Schueler A
Ther Innov Regul Sci; 2022 Jul; 56(4):637-650. PubMed ID: 35462609
[TBL] [Abstract][Full Text] [Related]
11. Estimands in published protocols of randomised trials: urgent improvement needed.
Kahan BC; Morris TP; White IR; Carpenter J; Cro S
Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
[TBL] [Abstract][Full Text] [Related]
12. Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic.
Qu Y; Lipkovich I
Ther Innov Regul Sci; 2021 Sep; 55(5):984-988. PubMed ID: 33983621
[TBL] [Abstract][Full Text] [Related]
13. Handling Missing Data and Drop Out in Hospice/Palliative Care Trials Through the Estimand Framework.
Grobler AC; Lee KJ; Wong A; Currow DC; Braat S
J Pain Symptom Manage; 2022 Apr; 63(4):e431-e439. PubMed ID: 34954068
[TBL] [Abstract][Full Text] [Related]
14. Estimands-A Basic Element for Clinical Trials.
Pohl M; Baumann L; Behnisch R; Kirchner M; Krisam J; Sander A
Dtsch Arztebl Int; 2021 Dec; 118(51-52):883-888. PubMed ID: 34857075
[TBL] [Abstract][Full Text] [Related]
15. Incorporating estimands into clinical trial statistical analysis plans.
Kang M; Kendall MA; Ribaudo H; Tierney C; Zheng L; Smeaton L; Lindsey JC
Clin Trials; 2022 Jun; 19(3):285-291. PubMed ID: 35257600
[TBL] [Abstract][Full Text] [Related]
16. Implementation of tripartite estimands using adherence causal estimators under the causal inference framework.
Qu Y; Luo J; Ruberg SJ
Pharm Stat; 2021 Jan; 20(1):55-67. PubMed ID: 33442928
[TBL] [Abstract][Full Text] [Related]
17. Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands.
Cro S; Kahan BC; Rehal S; Chis Ster A; Carpenter JR; White IR; Cornelius VR
BMJ; 2022 Aug; 378():e070146. PubMed ID: 35998928
[TBL] [Abstract][Full Text] [Related]
18. Application of the Estimand Framework to Anesthesia Trials.
De Silva AP; Leslie K; Braat S; Grobler AC
Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
[TBL] [Abstract][Full Text] [Related]
19. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
[TBL] [Abstract][Full Text] [Related]
20. Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
Bao W; Gaffney M; Pressler ML; Fayyad R; Wisemandle W; Beckerman B; Wolski KE; Nissen SE
Clin Trials; 2020 Oct; 17(5):535-544. PubMed ID: 32643966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
